Indian stock markets commenced the week with a subdued opening on Monday, marked by investor caution ahead of the Federal Reserve's anticipated interest-rate decision scheduled for this week.
The S&P BSE Sensex index experienced a decline of 165 points, or approximately 0.2%, settling at 81,968 during early trading hours. Similarly, the NSE Nifty index fell by 41 points, translating to a 0.2% decrease, landing at 24,727.
Among the notable decliners, Tech Mahindra, Sun Pharma, Bharti Airtel, Titan Company, and JSW Steel each registered losses of about 1%.
Conversely, Swiggy saw an uptick of 1.7%, and Zomato rose by 1%, driven by reports indicating an imminent announcement regarding GST input tax credit clarification.
Aurobindo Pharma climbed 1.2% following a favorable opinion from the CHMP of the European Medicines Agency for Zefylti (BP13), a biosimilar of filgrastim.
Bharat Forge's stock appreciated by over 1% as the company unveiled a €2.50 million investment to acquire a 25% equity stake in the Italian firm, Edgelab SpA.
Reliance Industries made modest gains after acquiring a 74% stake in a company developing industrial areas in Mumbai.
Afcons Infrastructure experienced a significant surge of 6% after securing a metro rail project valued at Rs. 1,007 crore.
Lastly, RITES surged 2.6% upon winning a contract worth Rs 297.67 crore from the Ministry of External Affairs (MEA).
The material has been provided by InstaForex Company - www.instaforex.com
The S&P BSE Sensex index experienced a decline of 165 points, or approximately 0.2%, settling at 81,968 during early trading hours. Similarly, the NSE Nifty index fell by 41 points, translating to a 0.2% decrease, landing at 24,727.
Among the notable decliners, Tech Mahindra, Sun Pharma, Bharti Airtel, Titan Company, and JSW Steel each registered losses of about 1%.
Conversely, Swiggy saw an uptick of 1.7%, and Zomato rose by 1%, driven by reports indicating an imminent announcement regarding GST input tax credit clarification.
Aurobindo Pharma climbed 1.2% following a favorable opinion from the CHMP of the European Medicines Agency for Zefylti (BP13), a biosimilar of filgrastim.
Bharat Forge's stock appreciated by over 1% as the company unveiled a €2.50 million investment to acquire a 25% equity stake in the Italian firm, Edgelab SpA.
Reliance Industries made modest gains after acquiring a 74% stake in a company developing industrial areas in Mumbai.
Afcons Infrastructure experienced a significant surge of 6% after securing a metro rail project valued at Rs. 1,007 crore.
Lastly, RITES surged 2.6% upon winning a contract worth Rs 297.67 crore from the Ministry of External Affairs (MEA).
The material has been provided by InstaForex Company - www.instaforex.com